Ben Arye Barak (CIK 1917165) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy NVCR (1,299 shares), Buy NVCR (50,125 shares), Buy NVCR (17,755 shares), Buy NVCR (108 shares), Buy NVCR (769 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | NovoCure Ltd (NVCR) | General Counsel | Buy | 1,299 | $14,484 |
| 2026-03-05 | NovoCure Ltd (NVCR) | General Counsel | Buy | 50,125 | $0 |
| 2026-03-03 | NovoCure Ltd (NVCR) | General Counsel | Buy | 17,755 | $0 |
| 2026-01-08 | NovoCure Ltd (NVCR) | General Counsel | Buy | 108 | $1,187 |
| 2025-07-01 | NovoCure Ltd (NVCR) | General Counsel | Buy | 769 | $11,635 |
来源：SEC Form 4 申报文件 · 截至 2026-07-01